SCHEMBL171049

SCHEMBL171049

Cc1cc(C)c(OCCN)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 1/20 0.41
ESR1 P03372 1/20 0.40
CD44 P16070 1/20 0.39
PLAU P00749 1/20 0.39
MCOLN3 Q8TDD5 1/20 0.38
CSNK2A1 P68400 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
GLA P06280 1/20 0.37
RAF1 P04049 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
CHEK1 O14757 1/20 0.35
KMT2A Q03164 1/20 0.35
DHFR P00374 1/20 0.35
PARP1 P09874 1/20 0.34
PARP3 Q9Y6F1 1/20 0.34
HTR1B P28222 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171081 0.80 RAF1 (0.39) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL10079637 0.79 KDM4E (0.50) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL171047 0.78 HTR1B (0.49) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL13602319 0.78 KDM4E (0.53) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL13602320 0.77 CYP1A2 (0.47) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL170572 0.77 ALDH1A1 (0.47) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL15783128 0.76 ESR1 (0.45) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL3525710 0.76 ALDH1A1 (0.57) ALDH1A1GAANPSR1KDM4EESR1
SCHEMBL22138644 0.75 ALDH1A1 (0.45) ALDH1A1POLBGAANPSR1KDM4E
SCHEMBL13631021 0.75 HTR2A (0.45) ALDH1A1POLBGAANPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158076-A1 Methylene Urea Derivatives MERCK PATENT GMBH (DE) 2013-06-20 US disclosed
US-20130158076-A1 Methylene Urea Derivatives MERCK PATENT GMBH (DE) 2013-06-20 US disclosed
US-8410143-B2 Methylene urea derivatives MERCK PATENT GMBH (DE) 2013-04-02 US disclosed
US-8410143-B2 Methylene urea derivatives MERCK PATENT GMBH (DE) 2013-04-02 US disclosed
EP-2426122-A1 Methylene urea derivative as RAF kinasse inhibitors Merck Patent GmbH (DE) 2012-03-07 EP disclosed
US-20090298885-A1 METHYLENE UREA DERIVATIVES MERCK PATENT GMBH (DE) 2009-12-03 US disclosed
US-20090298885-A1 METHYLENE UREA DERIVATIVES MERCK PATENT GMBH (DE) 2009-12-03 US disclosed
US-20090253688-A1 Semicarbazide derivatives as kinase inhibitors MERCK PATENT GMBH (DE) 2009-10-08 US disclosed
US-20090253688-A1 Semicarbazide derivatives as kinase inhibitors MERCK PATENT GMBH (DE) 2009-10-08 US disclosed
US-7589112-B2 Methylene urea derivatives MERCK PATENT GMBH (DE) 2009-09-15 US disclosed
US-20070191423-A1 Isoquinoline derivatives MERCK PATENT GMBH (DE) 2007-08-16 US disclosed
US-20070191423-A1 Isoquinoline derivatives MERCK PATENT GMBH (DE) 2007-08-16 US disclosed
US-20070191444-A1 Benzimidazolyl derivatives MERCK PATENT GMBH (DE) 2007-08-16 US disclosed
US-20070191444-A1 Benzimidazolyl derivatives MERCK PATENT GMBH (DE) 2007-08-16 US disclosed
US-20070161677-A1 Bisarylurea derivatives MERCK PATENT GMBH (DE) 2007-07-12 US disclosed
US-20070161677-A1 Bisarylurea derivatives MERCK PATENT GMBH (DE) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191444-A1 Benzimidazolyl derivatives JAK1, MARK1, RAF1 ALDH1A1 1382/4885POLB 2904/4885GAA 2382/4885
US-20070161677-A1 Bisarylurea derivatives BRAF, RAF1, NRAS ALDH1A1 764/4885POLB 919/4885GAA 1401/4885
US-20090298885-A1 METHYLENE UREA DERIVATIVES BRAF, RAF1, CMPK1 ALDH1A1 748/4885POLB 1145/4885GAA 3167/4885
US-20070191423-A1 Isoquinoline derivatives ABL1, MAP3K1, MAP3K2 ALDH1A1 2329/4885POLB 687/4885GAA 1611/4885
US-20130158076-A1 Methylene Urea Derivatives BRAF, RAF1, CMPK1 ALDH1A1 748/4885POLB 1145/4885GAA 3167/4885
US-20090253688-A1 Semicarbazide derivatives as kinase inhibitors MAP3K1, MAP3K6, MAP3K2 ALDH1A1 1023/4885POLB 1284/4885GAA 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.